APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lipid Contract Manufacturing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Lipid Contract Manufacturing Market Outlook and Growth Opportunities 2026

22 December 2025198 pages

Choose your research edition.

Industry ResearchLipid Contract Manufacturing Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Lipid Contract Manufacturing Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Lipid Contract Manufacturing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lipid Contract Manufacturing Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Lipid Contract Manufacturing Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Lipid Contract Manufacturing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Lipid Contract Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lipid Contract Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lipid Contract Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Lipid Contract Manufacturing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Lipid Contract Manufacturing market include Precision NanoSystems, Evonik, Merck KGaA, Genevant Sciences, Exelead, Avanti Polar Lipids, Nippon Fine Chemical, Lipoid and Polymun Scientific, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Lipid Contract Manufacturing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lipid Contract Manufacturing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lipid Contract Manufacturing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Lipid Contract Manufacturing market.

Lipid Contract Manufacturing Segment by Company

Precision NanoSystems

Evonik

Merck KGaA

Genevant Sciences

Exelead

Avanti Polar Lipids

Nippon Fine Chemical

Lipoid

Polymun Scientific

Corden Pharma

Acuitas Therapeutics

Lipid Contract Manufacturing Segment by Type

Liposomes

Lipid Nanoparticles

Lipid Contract Manufacturing Segment by Application

Preclinical

Clinical

Commercial

Lipid Contract Manufacturing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Lipid Contract Manufacturing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Lipid Contract Manufacturing key companies, revenue, market share, and recent developments.

3. To split the Lipid Contract Manufacturing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Lipid Contract Manufacturing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Lipid Contract Manufacturing significant trends, drivers, influence factors in global and regions.

6. To analyze Lipid Contract Manufacturing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lipid Contract Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lipid Contract Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lipid Contract Manufacturing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lipid Contract Manufacturing industry.

Chapter 3: Detailed analysis of Lipid Contract Manufacturing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Lipid Contract Manufacturing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Lipid Contract Manufacturing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Lipid Contract Manufacturing Industry Trends Table 2. Lipid Contract Manufacturing Industry Drivers Table 3. Lipid Contract Manufacturing Industry Opportunities and Challenges Table 4. Lipid Contract Manufacturing Industry Restraints Table 5. Global Lipid Contract Manufacturing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Lipid Contract Manufacturing Revenue Share by Company (2021-2026) Table 7. Global Lipid Contract Manufacturing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Lipid Contract Manufacturing Key Company Manufacturing Base & Headquarters Table 9. Global Lipid Contract Manufacturing Company, Product Type & Application Table 10. Global Lipid Contract Manufacturing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Lipid Contract Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Liposomes Table 15. Significant Companies of Lipid Nanoparticles Table 16. Global Lipid Contract Manufacturing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Lipid Contract Manufacturing Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Lipid Contract Manufacturing Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Lipid Contract Manufacturing Sales Value Share by Type (2021-2026) Table 20. Global Lipid Contract Manufacturing Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Preclinical Table 22. Significant Companies of Clinical Table 23. Significant Companies of Commercial Table 24. Global Lipid Contract Manufacturing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Lipid Contract Manufacturing Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Lipid Contract Manufacturing Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Lipid Contract Manufacturing Sales Value Share by Application (2021-2026) Table 28. Global Lipid Contract Manufacturing Sales Value Share by Application (2027-2032) Table 29. Global Lipid Contract Manufacturing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Lipid Contract Manufacturing Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Lipid Contract Manufacturing Sales Value Share by Region (2021-2026) Table 32. Global Lipid Contract Manufacturing Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Lipid Contract Manufacturing Sales Value Share by Region (2027-2032) Table 34. Global Lipid Contract Manufacturing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Lipid Contract Manufacturing Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Lipid Contract Manufacturing Sales Value Market Share by Country (2021-2026) Table 37. Global Lipid Contract Manufacturing Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Lipid Contract Manufacturing Sales Value Market Share by Country (2027-2032) Table 39. Precision NanoSystems Company Information Table 40. Precision NanoSystems Business Overview Table 41. Precision NanoSystems Lipid Contract Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Precision NanoSystems Lipid Contract Manufacturing Product Portfolio Table 43. Precision NanoSystems Recent Development Table 44. Evonik Company Information Table 45. Evonik Business Overview Table 46. Evonik Lipid Contract Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Evonik Lipid Contract Manufacturing Product Portfolio Table 48. Evonik Recent Development Table 49. Merck KGaA Company Information Table 50. Merck KGaA Business Overview Table 51. Merck KGaA Lipid Contract Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Merck KGaA Lipid Contract Manufacturing Product Portfolio Table 53. Merck KGaA Recent Development Table 54. Genevant Sciences Company Information Table 55. Genevant Sciences Business Overview Table 56. Genevant Sciences Lipid Contract Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Genevant Sciences Lipid Contract Manufacturing Product Portfolio Table 58. Genevant Sciences Recent Development Table 59. Exelead Company Information Table 60. Exelead Business Overview Table 61. Exelead Lipid Contract Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Exelead Lipid Contract Manufacturing Product Portfolio Table 63. Exelead Recent Development Table 64. Avanti Polar Lipids Company Information Table 65. Avanti Polar Lipids Business Overview Table 66. Avanti Polar Lipids Lipid Contract Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Avanti Polar Lipids Lipid Contract Manufacturing Product Portfolio Table 68. Avanti Polar Lipids Recent Development Table 69. Nippon Fine Chemical Company Information Table 70. Nippon Fine Chemical Business Overview Table 71. Nippon Fine Chemical Lipid Contract Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Nippon Fine Chemical Lipid Contract Manufacturing Product Portfolio Table 73. Nippon Fine Chemical Recent Development Table 74. Lipoid Company Information Table 75. Lipoid Business Overview Table 76. Lipoid Lipid Contract Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Lipoid Lipid Contract Manufacturing Product Portfolio Table 78. Lipoid Recent Development Table 79. Polymun Scientific Company Information Table 80. Polymun Scientific Business Overview Table 81. Polymun Scientific Lipid Contract Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Polymun Scientific Lipid Contract Manufacturing Product Portfolio Table 83. Polymun Scientific Recent Development Table 84. Corden Pharma Company Information Table 85. Corden Pharma Business Overview Table 86. Corden Pharma Lipid Contract Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Corden Pharma Lipid Contract Manufacturing Product Portfolio Table 88. Corden Pharma Recent Development Table 89. Acuitas Therapeutics Company Information Table 90. Acuitas Therapeutics Business Overview Table 91. Acuitas Therapeutics Lipid Contract Manufacturing Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Acuitas Therapeutics Lipid Contract Manufacturing Product Portfolio Table 93. Acuitas Therapeutics Recent Development Table 94. Research Programs/Design for This Report Table 95. Authors List of This Report Table 96. Secondary Sources Table 97. Primary Sources List of Figures Figure 1. Lipid Contract Manufacturing Product Image Figure 2. Global Lipid Contract Manufacturing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lipid Contract Manufacturing Market Size (2021-2032) & (US$ Million) Figure 4. Global Lipid Contract Manufacturing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Liposomes Image Figure 8. Lipid Nanoparticles Image Figure 9. Global Lipid Contract Manufacturing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Lipid Contract Manufacturing Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Lipid Contract Manufacturing Sales Value Share by Type (2021-2032) Figure 12. Preclinical Image Figure 13. Clinical Image Figure 14. Commercial Image Figure 15. Global Lipid Contract Manufacturing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Lipid Contract Manufacturing Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Lipid Contract Manufacturing Sales Value Share by Application (2021-2032) Figure 18. Global Lipid Contract Manufacturing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Lipid Contract Manufacturing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Lipid Contract Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 21. North America Lipid Contract Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Lipid Contract Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Lipid Contract Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Lipid Contract Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Lipid Contract Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Lipid Contract Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 27. South America Lipid Contract Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Lipid Contract Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Lipid Contract Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Liposomes
  • Lipid Nanoparticles
Applications
  • Preclinical
  • Clinical
  • Commercial
Companies covered
  • Precision NanoSystems
  • Evonik
  • Merck KGaA
  • Genevant Sciences
  • Exelead
  • Avanti Polar Lipids
  • Nippon Fine Chemical
  • Lipoid
  • Polymun Scientific
  • Corden Pharma
  • Acuitas Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Lipid Contract Manufacturing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Lipid Contract Manufacturing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Lipid Contract Manufacturing Market Dynamics
  1. 2.1 Lipid Contract Manufacturing Industry Trends
  2. 2.2 Lipid Contract Manufacturing Industry Drivers
  3. 2.3 Lipid Contract Manufacturing Industry Opportunities and Challenges
  4. 2.4 Lipid Contract Manufacturing Industry Restraints
3 Lipid Contract Manufacturing Market by Company
  1. 3.1 Global Lipid Contract Manufacturing Company Revenue Ranking in 2025
  2. 3.2 Global Lipid Contract Manufacturing Revenue by Company (2021-2026)
  3. 3.3 Global Lipid Contract Manufacturing Company Ranking (2024-2026)
  4. 3.4 Global Lipid Contract Manufacturing Company Manufacturing Base and Headquarters
  5. 3.5 Global Lipid Contract Manufacturing Company Product Type and Application
  6. 3.6 Global Lipid Contract Manufacturing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Lipid Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Lipid Contract Manufacturing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Lipid Contract Manufacturing Market by Type
  1. 4.1 Lipid Contract Manufacturing Type Introduction
  2. 4.1.1 Liposomes
  3. 4.1.2 Lipid Nanoparticles
  4. 4.2 Global Lipid Contract Manufacturing Sales Value by Type
  5. 4.2.1 Global Lipid Contract Manufacturing Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Lipid Contract Manufacturing Sales Value by Type (2021-2032)
  7. 4.2.3 Global Lipid Contract Manufacturing Sales Value Share by Type (2021-2032)
5 Lipid Contract Manufacturing Market by Application
  1. 5.1 Lipid Contract Manufacturing Application Introduction
  2. 5.1.1 Preclinical
  3. 5.1.2 Clinical
  4. 5.1.3 Commercial
  5. 5.2 Global Lipid Contract Manufacturing Sales Value by Application
  6. 5.2.1 Global Lipid Contract Manufacturing Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lipid Contract Manufacturing Sales Value by Application (2021-2032)
  8. 5.2.3 Global Lipid Contract Manufacturing Sales Value Share by Application (2021-2032)
6 Lipid Contract Manufacturing Regional Value Analysis
  1. 6.1 Global Lipid Contract Manufacturing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lipid Contract Manufacturing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Lipid Contract Manufacturing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Lipid Contract Manufacturing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Lipid Contract Manufacturing Sales Value (2021-2032)
  7. 6.3.2 North America Lipid Contract Manufacturing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Lipid Contract Manufacturing Sales Value (2021-2032)
  10. 6.4.2 Europe Lipid Contract Manufacturing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Lipid Contract Manufacturing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Lipid Contract Manufacturing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Lipid Contract Manufacturing Sales Value (2021-2032)
  16. 6.6.2 South America Lipid Contract Manufacturing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Lipid Contract Manufacturing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Lipid Contract Manufacturing Sales Value Share by Country, 2025 VS 2032
7 Lipid Contract Manufacturing Country-level Value Analysis
  1. 7.1 Global Lipid Contract Manufacturing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Lipid Contract Manufacturing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Lipid Contract Manufacturing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Lipid Contract Manufacturing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Lipid Contract Manufacturing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Lipid Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Lipid Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Precision NanoSystems
  2. 8.1.1 Precision NanoSystems Company Information
  3. 8.1.2 Precision NanoSystems Business Overview
  4. 8.1.3 Precision NanoSystems Lipid Contract Manufacturing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Precision NanoSystems Lipid Contract Manufacturing Product Portfolio
  6. 8.1.5 Precision NanoSystems Recent Developments
  7. 8.2 Evonik
  8. 8.2.1 Evonik Company Information
  9. 8.2.2 Evonik Business Overview
  10. 8.2.3 Evonik Lipid Contract Manufacturing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Evonik Lipid Contract Manufacturing Product Portfolio
  12. 8.2.5 Evonik Recent Developments
  13. 8.3 Merck KGaA
  14. 8.3.1 Merck KGaA Company Information
  15. 8.3.2 Merck KGaA Business Overview
  16. 8.3.3 Merck KGaA Lipid Contract Manufacturing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck KGaA Lipid Contract Manufacturing Product Portfolio
  18. 8.3.5 Merck KGaA Recent Developments
  19. 8.4 Genevant Sciences
  20. 8.4.1 Genevant Sciences Company Information
  21. 8.4.2 Genevant Sciences Business Overview
  22. 8.4.3 Genevant Sciences Lipid Contract Manufacturing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Genevant Sciences Lipid Contract Manufacturing Product Portfolio
  24. 8.4.5 Genevant Sciences Recent Developments
  25. 8.5 Exelead
  26. 8.5.1 Exelead Company Information
  27. 8.5.2 Exelead Business Overview
  28. 8.5.3 Exelead Lipid Contract Manufacturing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Exelead Lipid Contract Manufacturing Product Portfolio
  30. 8.5.5 Exelead Recent Developments
  31. 8.6 Avanti Polar Lipids
  32. 8.6.1 Avanti Polar Lipids Company Information
  33. 8.6.2 Avanti Polar Lipids Business Overview
  34. 8.6.3 Avanti Polar Lipids Lipid Contract Manufacturing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Avanti Polar Lipids Lipid Contract Manufacturing Product Portfolio
  36. 8.6.5 Avanti Polar Lipids Recent Developments
  37. 8.7 Nippon Fine Chemical
  38. 8.7.1 Nippon Fine Chemical Company Information
  39. 8.7.2 Nippon Fine Chemical Business Overview
  40. 8.7.3 Nippon Fine Chemical Lipid Contract Manufacturing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Nippon Fine Chemical Lipid Contract Manufacturing Product Portfolio
  42. 8.7.5 Nippon Fine Chemical Recent Developments
  43. 8.8 Lipoid
  44. 8.8.1 Lipoid Company Information
  45. 8.8.2 Lipoid Business Overview
  46. 8.8.3 Lipoid Lipid Contract Manufacturing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Lipoid Lipid Contract Manufacturing Product Portfolio
  48. 8.8.5 Lipoid Recent Developments
  49. 8.9 Polymun Scientific
  50. 8.9.1 Polymun Scientific Company Information
  51. 8.9.2 Polymun Scientific Business Overview
  52. 8.9.3 Polymun Scientific Lipid Contract Manufacturing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Polymun Scientific Lipid Contract Manufacturing Product Portfolio
  54. 8.9.5 Polymun Scientific Recent Developments
  55. 8.10 Corden Pharma
  56. 8.10.1 Corden Pharma Company Information
  57. 8.10.2 Corden Pharma Business Overview
  58. 8.10.3 Corden Pharma Lipid Contract Manufacturing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Corden Pharma Lipid Contract Manufacturing Product Portfolio
  60. 8.10.5 Corden Pharma Recent Developments
  61. 8.11 Acuitas Therapeutics
  62. 8.11.1 Acuitas Therapeutics Company Information
  63. 8.11.2 Acuitas Therapeutics Business Overview
  64. 8.11.3 Acuitas Therapeutics Lipid Contract Manufacturing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Acuitas Therapeutics Lipid Contract Manufacturing Product Portfolio
  66. 8.11.5 Acuitas Therapeutics Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst